Biorem Inc. (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 9,315 | 14,886 | 7,300 | 5,918 | 12,207 |
| Cost of Goods | 7,718 | 9,864 | 5,643 | 4,138 | 7,800 |
| Gross Profit | 1,597 | 5,021 | 1,657 | 1,780 | 4,407 |
| Operating Expenses | 1,302 | 1,996 | 1,144 | 1,219 | 1,403 |
| Operating Income | 295 | 3,026 | 513 | 561 | 3,004 |
| Interest Expense | 47 | 47 | 50 | 51 | 88 |
| Other Income | -8 | 4 | -1 | -45 | 73 |
| Pre-tax Income | 240 | 2,982 | 462 | 465 | 2,989 |
| Income Tax | 69 | 790 | 123 | 121 | 663 |
| Net Income Continuous | 171 | 2,192 | 340 | 344 | 2,327 |
| Net Income | $171 | $2,192 | $340 | $344 | $2,327 |
| EPS Basic Total Ops | 0.01 | 0.14 | 0.02 | 0.02 | 0.15 |
| EPS Basic Continuous Ops | 0.01 | 0.14 | 0.02 | 0.02 | 0.15 |
| EPS Diluted Total Ops | 0.01 | 0.12 | 0.02 | 0.02 | 0.14 |
| EPS Diluted Continuous Ops | 0.01 | 0.12 | 0.02 | 0.02 | 0.14 |
| EBITDA(a) | $427 | $3,215 | $587 | $590 | $3,275 |